Thymosin Alpha-1 5mg Dosing and Usage

Research-grade Thymosin Alpha-1 (Tα1) peptide dosing protocols for immune modulation and therapeutic research.

Quick Start Guide Full Protocol

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

8-week research protocol for Thymosin Alpha-1 immune modulation

Week	Daily Dose (mcg)	Units (per injection) (mL)
Week 1	300 mcg once daily	18 units (0.18 mL)
Weeks 2–8	500 mcg once daily	30 units (0.30 mL)

Frequency: Inject once daily subcutaneously. This 8-week protocol begins at 300 mcg to assess tolerance, then increases to a maintenance dose of 500 mcg daily from Week 2 onward.

Quickstart Highlights

Essential information for safe and effective research use

Reconstitute

3.0 mL bacteriostatic water → ~1.67 mg/mL

Typical daily range

300–500 mcg once daily

Easy measuring

At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

8-week research protocol for Thymosin Alpha-1 immune modulation

Week	Daily Dose (mcg)	Units (per injection) (mL)
Week 1	300 mcg once daily	18 units (0.18 mL)
Weeks 2–8	500 mcg once daily	30 units (0.30 mL)

Frequency: Inject once daily subcutaneously. This 8-week protocol begins at 300 mcg to assess tolerance, then increases to a maintenance dose of 500 mcg daily from Week 2 onward.

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

8-week research protocol for Thymosin Alpha-1 immune modulation

Week	Daily Dose (mcg)	Units (per injection) (mL)
Week 1	300 mcg once daily	18 units (0.18 mL)
Weeks 2–8	500 mcg once daily	30 units (0.30 mL)

Frequency: Inject once daily subcutaneously. This 8-week protocol begins at 300 mcg to assess tolerance, then increases to a maintenance dose of 500 mcg daily from Week 2 onward.